Eloxx Pharmaceuticals, Inc.
ELOX$64M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaARLINGTON
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
ELOX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Eloxx Pharmaceuticals, Inc.'s next FDA catalyst?→
Eloxx Pharmaceuticals, Inc.'s (ELOX) next tracked catalyst is a Earnings expected November 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ELOX biotech catalysts?→
Add ELOX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Eloxx Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply